NTRA
Natera, Inc.
Natera, Inc. (NTRA) has 54 SEC Form 4 filings (257 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is Director Sheena Jonathan with 15 filings. Insiders have net sold $124.1M over the trailing 6 months.
- Industry:Medical - Diagnostics & Research
- CEO:Steven Leonard Chapman
- Employees:6,140
- HQ:Austin, TX, US
- IPO:2015-07-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$131.2M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Market Cap
$39.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CO-FOUNDER | Sale | 3,150 | $837K | Jul 16 | SEC ↗ | |
| EXECUTIVE CHAIRMAN | Sale | 1,000 | $280K | Jul 9 | SEC ↗ | |
| SEC. AND CHIEF LEGAL OFFICER | Sale | 16,800 | $4.6M | Jul 7 | SEC ↗ | |
| PRESIDENT, CLINICALDIAGNOSTICS | Sale | 3,000 | $819K | Jul 7 | SEC ↗ | |
| SEC. AND CHIEF LEGAL OFFICER | Sale | 33,600 | $8.5M | Jun 27 | SEC ↗ | |
ROSENMAN HERMFirst filing | Director | Sale | 16,530 | $4.1M | Jun 27 | SEC ↗ |
| CO-FOUNDER | Sale | 1,500 | $330K | Jun 23 | SEC ↗ | |
Chapman Rowan EFirst filing | Director | Sale | 2,964 | $643K | Jun 18 | SEC ↗ |
| CO-FOUNDER | Sale | 3,150 | $665K | Jun 18 | SEC ↗ | |
| EXECUTIVE CHAIRMAN | Sale | 50,000 | $10.7M | Jun 17 | SEC ↗ | |
| EXECUTIVE CHAIRMAN | Sale | 50,000 | $10.7M | Jun 17 | SEC ↗ | |
Marcus Gail BoxerFirst filing | Director | Sale | 11,000 | $2.4M | Jun 10 | SEC ↗ |
| CEO AND PRESIDENT | Sale | 41,124 | $9.1M | Jun 6 | SEC ↗ | |
| PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,652 | $335K | May 29 | SEC ↗ | |
| PRESIDENT, CHIEF BUS. OFFICER | Sale | 1,438 | $292K | May 29 | SEC ↗ | |
| CO-FOUNDER | Sale | 3,150 | $657K | May 16 | SEC ↗ | |
| CO-FOUNDER | Sale | 1,500 | $302K | May 16 | SEC ↗ | |
| EXECUTIVE CHAIRMAN | Sale | 722 | $149K | May 7 | SEC ↗ | |
| EXECUTIVE CHAIRMAN | Sale | 6,986 | $1.5M | May 7 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 313 | $65K | May 6 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 482 | $101K | May 6 | SEC ↗ | |
| Insider | Sale | 107 | $22K | May 6 | SEC ↗ | |
| PRESIDENT, CLINICALDIAGNOSTICS | Sale | 3,405 | $694K | May 6 | SEC ↗ | |
| PRESIDENT, CHIEF BUS. OFFICER | Sale | 291 | $60K | May 6 | SEC ↗ | |
| CEO AND PRESIDENT | Sale | 902 | $186K | May 6 | SEC ↗ | |
| SEC. AND CHIEF LEGAL OFFICER | Sale | 330 | $68K | May 6 | SEC ↗ | |
Brophy Michael BurkesFirst in 6 months | CHIEF FINANCIAL OFFICER | Sale | 1,993 | $407K | Apr 30 | SEC ↗ |
Brophy Michael BurkesFirst in 6 months | CHIEF FINANCIAL OFFICER | Sale | 3,070 | $595K | Apr 30 | SEC ↗ |
| CEO AND PRESIDENT | Sale | 5,838 | $1.2M | Apr 30 | SEC ↗ | |
Fesko JohnFirst filing | PRESIDENT, CHIEF BUS. OFFICER | Sale | 1,688 | $345K | Apr 30 | SEC ↗ |
| PRESIDENT, CLINICALDIAGNOSTICS | Sale | 2,182 | $445K | Apr 30 | SEC ↗ | |
RABINOWITZ DANIELFirst filing | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,861 | $380K | Apr 30 | SEC ↗ |
| Insider | Sale | 473 | $96K | Apr 30 | SEC ↗ | |
| Insider | Sale | 3,071 | $603K | Apr 30 | SEC ↗ | |
| Insider | Sale | 3,070 | $608K | Mar 20 | SEC ↗ | |
| Insider | Sale | 1,500 | $300K | Mar 20 | SEC ↗ | |
Rabinowitz MatthewFirst filing | EXECUTIVE CHAIRMAN | Sale | 75,000 | $14.3M | Mar 16 | SEC ↗ |
Rabinowitz MatthewFirst filing | EXECUTIVE CHAIRMAN | Sale | 75,000 | $14.2M | Mar 16 | SEC ↗ |
Rabinowitz MatthewFirst filing | EXECUTIVE CHAIRMAN | Sale | 50,000 | $9.8M | Mar 16 | SEC ↗ |
| PRESIDENT, CLINICALDIAGNOSTICS | Sale | 3,000 | $600K | Mar 3 | SEC ↗ | |
Moshkevich SolomonFirst filing | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 3,000 | $694K | Feb 4 | SEC ↗ |
Moshkevich SolomonFirst filing | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,639 | $378K | Feb 4 | SEC ↗ |
Chapman Steven LeonardFirst filing | CEO AND PRESIDENT | Sale | 85,299 | $19.7M | Feb 4 | SEC ↗ |
Chapman Steven LeonardFirst filing | CEO AND PRESIDENT | Sale | 4,725 | $1.1M | Feb 4 | SEC ↗ |
Sheena JonathanFirst in 3 months | Insider | Sale | 1,500 | $366K | Jan 27 | SEC ↗ |
Baynes Roy D.First filing | Insider | Sale | 5,112 | $1.1M | Nov 21 | SEC ↗ |
Baynes Roy D.First filing | Insider | Sale | 7,668 | $1.7M | Nov 21 | SEC ↗ |
Brophy Michael BurkesFirst filing | CHIEF FINANCIAL OFFICER | Sale | 781 | $150K | Oct 29 | SEC ↗ |
Brophy Michael BurkesFirst filing | CHIEF FINANCIAL OFFICER | Sale | 2,415 | $462K | Oct 29 | SEC ↗ |
Brophy Michael BurkesFirst filing | CHIEF FINANCIAL OFFICER | Sale | 1,867 | $356K | Oct 29 | SEC ↗ |
| Insider | Sale | 3,070 | $539K | Oct 17 | SEC ↗ | |
| Insider | Sale | 1,500 | $268K | Oct 17 | SEC ↗ | |
Sheena JonathanFirst filing | Insider | Sale | 3,070 | $540K | Sep 22 | SEC ↗ |
Sheena JonathanFirst filing | Insider | Sale | 11,000 | $2.0M | Sep 22 | SEC ↗ |
Related companies
Natera, Inc. is in the Healthcare sector.